The trademark application Myllia Biotechnology was filed by Aelian Biotechnology GmbH, a corporation established under the laws of the Republic of Austria (the "Applicant"). The application was published for oppositions on February 6, 2022, and it was registered by office on May 16, 2022 without any oppositions.
The application was filed in German (English was selected as the second language).
Goods And Services
The mark was filed in class 42 with following description of goods:
Consultancy relating to biotechnology
Research relating to biotechnology
Research and development in the field of biotechnology
Research and development in the pharmaceutical and biotechnology fields
Scientific research for medical purposes
Scientific research relating to genetics
Scientific research in the field of genetics and genetic engineering
Provision of research services
Biomedical research services
Pharmaceutical research services
Genetic research
Biological research
Research on the subject of pharmaceuticals
Computer aided industrial research services
Research laboratories
Consultancy services relating to technological research
Scientific and industrial research
Pharmaceutical research and development
Scientific research relating to biology
Biotechnological research relating to industry
Biological research laboratory services
Research in the field of gene therapy
Research to develop new products
Research and development services in the field of gene expression systems
Research and development services in the field of immunology
Research and development services in the field of cytology
Research and development services in the field of immunohistology
Research and development in the field of diagnostic preparations
Research and development for the pharmaceutical industry
Analysis of human serum for medical research
Research and development in the field of microorganisms and cells